CRISPR-AsCas12a with crRNA-Free Collateral Cleavage Activity for Electrochemical Diagnosis of HER2-Positive Breast Cancer

Abstract The CRISPR-Cas12a system has revolutionized molecular diagnostics; however, the strict requirement of crRNAs and target DNA for collateral cleavage activation restricts its flexibility in non-nucleic acid diagnostics. Herein, we demonstrate that AsCas12a exhibits an RNA-free collateral cleavage activity with the presence of manganese ions (Mn2+), which preferentially cleaves single-stranded DNA efficiently. Mechanistically, kinetic analyses reveal that AsCas12a exhibits a significantly higher binding affinity for Mn2+ than for magnesium ion (Mg2+), while molecular dynamics simulations suggest that Mn2+ coordination induces conformational changes to expose the RuvC endonuclease domain. Harnessing this unique property, an enzymatic cascade-amplified electrochemical biosensor integrating manganese nanoflowers is reported for the diagnosis of human epidermal growth factor receptor 2 (HER2)-positive breast cancer. By equipping screen-printed gold electrodes with DNA reporters, this diagnostic tool enables high-precision HER2 quantification and successfully distinguishes various HER2-related cell lines. Furthermore, the biosensor has been extended to analyze HER2-positive exosomes, facilitating the dynamic tracking of serum exosome levels in tumor-bearing nude mice to evaluate therapeutic efficacy and accurately distinguish HER2-positive breast cancer patients in clinical samples. This RNA-free Cas12a system may provide new insights into CRISPR-based non-nucleic acid detection, emerging as a powerful tool for dynamic tumor monitoring and precision oncology.

Authors

Institutions

Publication Details

Journal
ACS Sensors
Published
2026-11-14
DOI
https://doi.org/10.1021/acssensors.6c03688
Primary Topic
Advanced biosensing and bioanalysis techniques
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

CRISPR-AsCas12a with crRNA-Free Collateral Cleavage Activity for Electrochemical Diagnosis of HER2-Positive Breast Cancer

Tianci Zhou, Genxi Li, Yongmei Yin, Shuai Wu et al.
ACS Sensors
Advanced biosensing and bioanalysis techniques
article

CRISPR-AsCas12a with crRNA-Free Collateral Cleavage Activity for Electrochemical Diagnosis of HER2-Positive Breast Cancer

Tianci Zhou, Genxi Li, Yongmei Yin, Shuai Wu, Yanting Sun, Zeying Li, Chang Ye, Tianyu Zeng, Jialin Xu, Ying Deng
article en

Abstract

Abstract The CRISPR-Cas12a system has revolutionized molecular diagnostics; however, the strict requirement of crRNAs and target DNA for collateral cleavage activation restricts its flexibility in non-nucleic acid diagnostics. Herein, we demonstrate that AsCas12a exhibits an RNA-free collateral cleavage activity with the presence of manganese ions (Mn2+), which preferentially cleaves single-stranded DNA efficiently. Mechanistically, kinetic analyses reveal that AsCas12a exhibits a significantly higher binding affinity for Mn2+ than for magnesium ion (Mg2+), while molecular dynamics simulations suggest that Mn2+ coordination induces conformational changes to expose the RuvC endonuclease domain. Harnessing this unique property, an enzymatic cascade-amplified electrochemical biosensor integrating manganese nanoflowers is reported for the diagnosis of human epidermal growth factor receptor 2 (HER2)-positive breast cancer. By equipping screen-printed gold electrodes with DNA reporters, this diagnostic tool enables high-precision HER2 quantification and successfully distinguishes various HER2-related cell lines. Furthermore, the biosensor has been extended to analyze HER2-positive exosomes, facilitating the dynamic tracking of serum exosome levels in tumor-bearing nude mice to evaluate therapeutic efficacy and accurately distinguish HER2-positive breast cancer patients in clinical samples. This RNA-free Cas12a system may provide new insights into CRISPR-based non-nucleic acid detection, emerging as a powerful tool for dynamic tumor monitoring and precision oncology.

ACS Sensors
Shanghai University (CN), Jiangsu Province Hospital (CN), Nanjing Medical University (CN), Nanjing University (CN)
Advanced biosensing and bioanalysis techniques
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon